We are live on ! Find out more
IMGN

Immunogen Inc

Delisted

IMGN was delisted on the 9th of February, 2024.

141 hedge funds and large institutions have $795M invested in Immunogen Inc in 2014 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 51 increasing their positions, 36 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

209% more call options, than puts

Call options by funds: $7.11M | Put options by funds: $2.3M

42% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 36

25% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 16

3% more funds holding

Funds holding: 137141 (+4)

10% less capital invested

Capital invested by funds: $887M → $795M (-$92.6M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
141
Holders Change
+4
Holders Change %
+2.92%
% of All Funds
4.09%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
20
Increased
51
Reduced
36
Closed
16
Calls
$7.11M
Puts
$2.3M
Net Calls
+$4.81M
Net Calls Change
-$1.57M
Name Holding Trade Value Shares
Change
Change in
Stake
BRWA
151
B. Riley Wealth Advisors
Florida
-$5.33K -450 Closed
Bessemer Group
152
Bessemer Group
New Jersey
-$3K -290 Closed
MBT
153
Monroe Bank & Trust
Michigan
-$2K -145 Closed
ECM
154
Estabrook Capital Management
New York
-$1.61K -136 Closed
VAM
155
Visionary Asset Management
Texas
-$1K -104 Closed
JG
156
Jefferies Group
New York
-$1K -103 Closed

IMGN Hedge Fund Activity: Q3 2014 in Review

141 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q3 2014, worth a combined $795M — down 10% from $887M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new IMGN positions and 16 closed out — a net gain of 4 holders — while 51 added to existing stakes and 36 trimmed.

The largest buyer was First Trust Advisors, adding an estimated $19.1M. The largest seller was Fidelity Investments, cutting an estimated $15.6M.

  • 141 institutional investors held Immunogen Inc (IMGN) as of Q3 2014, up from 137 in Q2 2014.
  • Funds reported $795M of Immunogen Inc stock for Q3 2014, down 10% quarter-over-quarter.
  • 20 funds opened new Immunogen Inc positions in Q3 2014 and 16 closed out, a net change of +4 holders.
  • The largest Immunogen Inc buyer in Q3 2014 was First Trust Advisors, an estimated $19.1M added.
  • The largest Immunogen Inc seller in Q3 2014 was Fidelity Investments, an estimated $15.6M sold.

Based on aggregated 13F filings for Q3 2014.